Brovana Sepracor Inc. - Treatment for Chronic Obstructive Pulmonary Disease
Brovana is a long-acting beta2-agonist for inhalation via a nebulizer, used for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.Posted: October 2006
Related Articles:
- Sepracor's Arformoterol NDA Filed by FDA; Drug Candidate for Chronic Obstructive Pulmonary Disease Moves Into Formal Review - February 13, 2006
- Sepracor Announces Submission of Arformoterol NDA to FDA for Chronic Obstructive Pulmonary Disease - December 13, 2005
Brovana (arformoterol tartrate) FDA Approval History
